Barrett's oESophagus trial 3 (BEST3): study protocol for a randomised controlled trial comparing the Cytosponge-TFF3 test with usual care to facilitate the diagnosis of oesophageal pre-cancer in primary care patients with chronic acid reflux. (2018)
Attributed to:
Oesophago-gastric adenocarcinoma: understanding disease pathogenesis and applications to earlier diagnosis
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1186/s12885-018-4664-3
PubMed Identifier: 30075763
Publication URI: http://europepmc.org/abstract/MED/30075763
Type: Journal Article/Review
Volume: 18
Parent Publication: BMC cancer
Issue: 1
ISSN: 1471-2407